A carregar...

Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison

INTRODUCTION: Prophylaxis with recombinant factor VIII (rFVIII) is the current standard of care for haemophilia A. Several approaches have been used to extend the half-life of rFVIII to improve prophylaxis outcomes. An indirect comparison of pivotal clinical trial data was performed to evaluate the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Ther
Main Authors: Hakimi, Zalmai, Santagostino, Elena, Postma, Maarten J., Nazir, Jameel
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889532/
https://ncbi.nlm.nih.gov/pubmed/33377987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01599-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!